RxSight (RXST) Depreciation & Amortization (CF) (2020 - 2026)
RxSight posted quarterly Depreciation & Amortization (CF) of $834000.0 for Q1 2026, up 7.47% year-on-year from $776000.0 in Q1 2025, and down 2.0% on a QoQ basis from $851000.0 in Q4 2025.
RxSight (RXST) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $834000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 7.47% year-over-year to $834000.0; the trailing twelve-month figure through Mar 2026 stood at $3.3 million (up 2.72% YoY), and the FY2025 full-year result was $3.3 million, down 8.64% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $834000.0, down from $851000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.1 million in Q3 2024 and bottomed at $515000.0 in Q4 2024.
- The 5-year median for Depreciation & Amortization (CF) is $941000.0 (2022), against an average of $919823.5.
- The widest annual swing landed in 2024, when Depreciation & Amortization (CF) plunged 51.0%; it then surged 65.24% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $918000.0 in 2022, then increased by 14.49% to $1.1 million in 2023, then slumped by 51.0% to $515000.0 in 2024, then soared by 65.24% to $851000.0 in 2025, then retreated by 2.0% to $834000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $834000.0 (Q1 2026), $851000.0 (Q4 2025), and $854000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | RxSight | 215.82 Mn | -2.06 Mn | 23.50 Mn | 834,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 834,000.00 |
| Mar 31, 2026 | 834,000.00 |
| Dec 31, 2025 | 851,000.00 |
| Dec 31, 2025 | 851,000.00 |
| Sep 30, 2025 | 854,000.00 |
| Sep 30, 2025 | 854,000.00 |
| Jun 30, 2025 | 785,000.00 |
| Jun 30, 2025 | 785,000.00 |
| Mar 31, 2025 | 776,000.00 |
| Mar 31, 2025 | 776,000.00 |
| Dec 31, 2024 | 515,000.00 |
| Dec 31, 2024 | 515,000.00 |
| Sep 30, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 812,000.00 |
| Jun 30, 2024 | 812,000.00 |
| Mar 31, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.12 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Sep 30, 2023 | 1.08 Mn |
| Jun 30, 2023 | 989,000.00 |
| Jun 30, 2023 | 989,000.00 |
| Mar 31, 2023 | 955,000.00 |
| Mar 31, 2023 | 955,000.00 |
| Dec 31, 2022 | 918,000.00 |
| Dec 31, 2022 | 918,000.00 |
| Sep 30, 2022 | 941,000.00 |
| Sep 30, 2022 | 941,000.00 |
| Jun 30, 2022 | 1.01 Mn |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.02 Mn |
| Mar 31, 2022 | 1.02 Mn |
| Dec 31, 2021 | 1.03 Mn |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 1.01 Mn |
| Sep 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 986,000.00 |
| Jun 30, 2021 | 986,000.00 |
| Mar 31, 2021 | 958,000.00 |
| Mar 31, 2021 | 958,000.00 |
| Dec 31, 2020 | 987,000.00 |
| Dec 31, 2020 | 987,000.00 |
| Sep 30, 2020 | 1.03 Mn |
| Sep 30, 2020 | 1.03 Mn |